Trial Profile
Study of the Efficiency of a Treatment by Bumetanide in a Population of Autistic Children.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Jun 2012
Price :
$35
*
At a glance
- Drugs Bumetanide (Primary)
- Indications Autistic disorder
- Focus Therapeutic Use
- Acronyms BUMEA
- 20 Dec 2011 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.
- 20 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.